Back to search results
NCT05236556

Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF IV

Enrolling by Invitation
NAAges 18+InterventionalTreatment
University of Massachusetts, Worcester
~5,094 participants
Updated 2026-03-30 on ClinicalTrials.gov
What's tested:Best practice advisory (BPA)

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Initiation of Oral Anticoagulation (AC) Use
Measured over 12 months
+1 more outcome measured

Conditions

Atrial Fibrillation

Explore related trials

Atrial FibrillationAtrial Flutter

Where it's being run

2 sites across 2 states
Florida1
Massachusetts1

Study leadership

  • Alok Kapoor, MD · PRINCIPAL_INVESTIGATOR · UMass Chan Medical School

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Providers caring for patients aged 18 years and older with international classification of disease 10th revision (ICD-10) diagnostic code consistent with atrial fibrillation (AF) or atrial flutter who had a visit with a primary care provider or cardiovascular medicine specialist in the previous one year with the diagnosis of AF present as an active diagnosis in the electronic health record (EHR).
Patients aged 18 years and older with ICD-10 diagnostic code consistent with AF or atrial flutter who had a visit with a primary care provider or cardiovascular medicine specialist in the previous one year with the diagnosis of AF present as an active diagnosis in the EHR.

Exclusion

Left atrial appendage closure
Hospice status
Providers who do not care for patients aged 18 years and older with ICD-10 diagnostic code consistent with AF or atrial flutter who had a visit with a primary care provider or cardiovascular medicine specialist in the previous one year with the diagnosis of AF present as an active diagnosis in the EHR.
Patients under the age of 18; patients without a ICD-10 diagnostic code consistent with AF or atrial flutter who had a visit with a primary care provider or cardiovascular medicine specialist in the previous one year with the diagnosis of AF present as an active diagnosis in the EHR. Patients will also be excluded from this study if they are known to be pregnant or a prisoner.

What this trial measures

  • Initiation of Oral Anticoagulation (AC) Use12 months

    The number of participants who initiate AC will be measured using the first encounter for each participant in the 12 months after randomization of providers and launch of the enhanced alert. To count as an AC initiation, a participant will have to have presence of an anticoagulant on his/her current medication list or an international normalized ratio (INR) lab value 1.5 or greater in the two months following the index encounter.

  • Length of Duration for Oral Anticoagulation (AC) Use12 months

    The number of days participants continue on AC for one year after AC initiation will be tracked. Up to one month off AC such as for bleeding or surgical procedure will be permitted so long as the participant resumes AC prior to the end of the 12 month follow up.